Serum B-Cell Maturation Antigen (BCMA) Levels Differentiate Primary Antibody Deficiencies-Reference-Cited by-同舟云学术

Serum B-Cell Maturation Antigen (BCMA) Levels Differentiate Primary Antibody Deficiencies

Published:2020-01 Issue:1 Volume:8 Page:283-291.e1
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Maglione Paul J.,Ko Huaibin M.,Tokuyama Minami,Gyimesi Gavin,Soof Camilia,Li Mingjie,Sanchez Eric,Chen Haiming,Radigan Lin,Berenson James,Cunningham-Rundles Charlotte

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference41 articles.

1. Primary immune deficiencies in the adult: a previously underrecognized common condition;Rosenberg;J Allergy Clin Immunol Pract,2016

2. The nuts and bolts of immunoglobulin treatment for antibody deficiency;Wasserman;J Allergy Clin Immunol Pract,2016

3. Lung disease in primary antibody deficiencies;Schussler;J Allergy Clin Immunol Pract,2016

4. Differentiation of common variable immunodeficiency from IgG deficiency;Filion;J Allergy Clin Immunol Pract,2019

5. The expanding field of secondary antibody deficiency: causes, diagnosis, and management;Patel;Front Immunol,2019

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cross-talk between immune cells and tumor cells in non-Hodgkin lymphomas arising in common variable immunodeficiency;Expert Review of Clinical Immunology;2024-09-04

2. “Where are they now?” Catching up with the 2019 AAAAI Faculty Development Awardees;Journal of Allergy and Clinical Immunology;2024-09

3. An Exploratory Approach of Clinically Useful Biomarkers of Cvid by Logistic Regression;Journal of Clinical Immunology;2024-06-07

4. An Exploratory Approach of Clinically Useful Biomarkers of Cvid by Logistic Regression;2023-12-15

5. Plasma levels of BCMA-positive extracellular vesicles correlate to response and side effects in myeloma patients treated with belantamab-mafodotin;Oncotarget;2023-12-01